CTNNB1 and colorectal carcinoma: In fact, Duan et al. demonstrated that S100A8/A9 contributed survival and migration of colorectal carcinoma cells through Wnt/beta-catenin pathway, emphasizing that it might be a potential therapeutic target in the treatment of colorectal carcinoma [19].